TRI 5.26% 2.0¢ trivarx ltd

Ann: US FDA advises further data needed for MEBsleep approval, page-5

  1. 689 Posts.
    lightbulb Created with Sketch. 112
    Yeh it looks like the remaining are long term investors with the recent selloff by day traders.

    Regarding the detail A similar pharmaceutical company Pharmaxis (PXS) received detailed guidance prior to their approval.

    Here's an article from PXS from the detailed guidance announcements.

    https://hotcopper.com.au/data/attachments/2765/2765074-e389e09c1d3bcdaea3021f100f441c7f.jpg




 
watchlist Created with Sketch. Add TRI (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.